iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy DOI Creative Commons
Paola Rispoli, Tatiana Scandiuzzi Piovesan, Giuliana Decorti

и другие.

WIREs Mechanisms of Disease, Год журнала: 2023, Номер 16(1)

Опубликована: Сен. 28, 2023

Abstract Induced pluripotent stem cells (iPSCs), obtained by reprogramming different somatic cell types, represent a promising tool for the study of drug toxicities, especially in context personalized medicine. Indeed, these retain same genetic heritage donor, allowing development models. In addition, they useful adverse reactions (ADRs) special populations, such as pediatric patients, which are often poorly represented clinical trials due to ethical issues. Particularly, iPSCs can be differentiated into any tissue human body, following several protocols use stimuli induce specific differentiation processes. Differentiated also maintain and therefore suitable pharmacological studies; moreover, iPSC‐derived valuable investigation mechanisms underlying physiological iPSCs‐derived organoids another important ADRs. Precisely, vitro 3D models better native organ, both from structural functional point view. Moreover, way 2D models, appropriate since donor. comparison other present advantages terms versatility, patient‐specificity, This review aims provide an updated report employment iPSCs, derived these, article is categorized under: Cancer > Stem Cells Development

Язык: Английский

Brain organoid model systems of neurodegenerative diseases: recent progress and future prospects DOI Creative Commons
Saleem Shaikh,

Luqman Siddique,

Hafsah T. Khalifey

и другие.

Frontiers in Neuroscience, Год журнала: 2025, Номер 19

Опубликована: Май 23, 2025

Neurological diseases are a leading cause of disability, morbidity, and mortality, affecting 43% the world’s population. The detailed study neurological diseases, testing drugs, repair site-specific defects require physiologically relevant models that recapitulate key events dynamic neurodevelopmental processes in highly organized fashion. As an evolving technology, self-organizing self-assembling brain organoids offer advantage modeling different stages development 3D microenvironment. Herein, we review utility, advantages, limitations latest breakthroughs organoid endeavors context three most prevalent neurodegenerative diseases—Alzheimer’s, Parkinson’s, Huntington’s disease. We conclude with perspective on future prospects their myriad possible applications translational medicine.

Язык: Английский

Процитировано

0

Brain Organoids and Assembloids—From Disease Modeling to Drug Discovery DOI Creative Commons

Aderonke O. Ajongbolo,

Sigrid A. Langhans

Cells, Год журнала: 2025, Номер 14(11), С. 842 - 842

Опубликована: Июнь 4, 2025

Brain organoids are self-organized, three-dimensional (3D) aggregates derived from human embryonic stem cells, induced pluripotent or primary organs with cell types and cellular architectures resembling those of the developing brain. Recent studies have shown use region-specific brain for modeling various diseases ranging neurodevelopmental neurodegenerative to different cancers, which numerous applications in fundamental research development new drugs, personalized treatment, regenerative medicine. Consequently, drug discovery is complex challenging still an emerging area this field. This review article summarizes cells used organoid generation, organoids, functional assays their characterization. In addition, we discuss pediatric as well application assembloids, tumoroids cancer neuroscience. We further explore recent advances using high-throughput screening improve discovery.

Язык: Английский

Процитировано

0

Human Brain Organoids in Migraine Research: Pathogenesis and Drug Development DOI Open Access
Parisa Gazerani

International Journal of Molecular Sciences, Год журнала: 2023, Номер 24(4), С. 3113 - 3113

Опубликована: Фев. 4, 2023

Human organoids are small, self-organized, three-dimensional (3D) tissue cultures that have started to revolutionize medical science in terms of understanding disease, testing pharmacologically active compounds, and offering novel ways treat disease. Organoids the liver, kidney, intestine, lung, brain been developed recent years. used for pathogenesis investigating therapeutic options neurodevelopmental, neuropsychiatric, neurodegenerative, neurological disorders. Theoretically, several disorders can be modeled with aid human organoids, hence potential exists migraine its treatment organoids. Migraine is considered a disorder non-neurological abnormalities symptoms. Both genetic environmental factors play essential roles clinical manifestations. Several types migraines classified, example, without aura, from patients these study (e.g., channelopathy calcium channels) stressors chemical mechanical). In models, drug candidates purposes also tested. Here, limitations studying communicated generate motivation stimulate curiosity further research. This must, however, alongside complexity concept neuroethical aspects topic. Interested researchers invited join network protocol development hypothesis presented here.

Язык: Английский

Процитировано

5

Direct Cell Reprogramming and Phenotypic Conversion: An Analysis of Experimental Attempts to Transform Astrocytes into Neurons in Adult Animals DOI Creative Commons

Rachel Dennison,

Esteban Usuga,

Harriet Chen

и другие.

Cells, Год журнала: 2023, Номер 12(4), С. 618 - 618

Опубликована: Фев. 14, 2023

Central nervous system (CNS) repair after injury or disease remains an unresolved problem in neurobiology research and unmet medical need. Directly reprogramming converting astrocytes to neurons (AtN) adult animals has been investigated as a potential strategy facilitate brain spinal cord recovery advance fundamental biology. Conceptually, AtN strategies rely on forced expression repression of lineage-specific transcription factors make endogenous become “induced neurons” (iNs), presumably without re-entering any pluripotent multipotent states. The AtN-derived cells have reported manifest certain neuronal functions vivo. However, this approach raised many new questions alternative explanations regarding the biological features end products (e.g., iNs versus neuron-like cells, neural functional changes, etc.), developmental biology underpinnings, neurobiological essentials. For paper per se, we proposed draw unconventional distinction between direct cell conversion reprogramming, relative somatic nuclear transfer, based experimental methods utilized initiate transformation process, aiming promote more in-depth mechanistic exploration. Moreover, summarized current tactics employed for induction, comparisons bench endeavors concerning outcome tangibility, discussion issues published protocols. Lastly, urgency clearly define/devise theoretical frameworks, bases, specifics experimentally validate primary data studies was highlighted.

Язык: Английский

Процитировано

5

iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy DOI Creative Commons
Paola Rispoli, Tatiana Scandiuzzi Piovesan, Giuliana Decorti

и другие.

WIREs Mechanisms of Disease, Год журнала: 2023, Номер 16(1)

Опубликована: Сен. 28, 2023

Abstract Induced pluripotent stem cells (iPSCs), obtained by reprogramming different somatic cell types, represent a promising tool for the study of drug toxicities, especially in context personalized medicine. Indeed, these retain same genetic heritage donor, allowing development models. In addition, they useful adverse reactions (ADRs) special populations, such as pediatric patients, which are often poorly represented clinical trials due to ethical issues. Particularly, iPSCs can be differentiated into any tissue human body, following several protocols use stimuli induce specific differentiation processes. Differentiated also maintain and therefore suitable pharmacological studies; moreover, iPSC‐derived valuable investigation mechanisms underlying physiological iPSCs‐derived organoids another important ADRs. Precisely, vitro 3D models better native organ, both from structural functional point view. Moreover, way 2D models, appropriate since donor. comparison other present advantages terms versatility, patient‐specificity, This review aims provide an updated report employment iPSCs, derived these, article is categorized under: Cancer > Stem Cells Development

Язык: Английский

Процитировано

5